Government policies make Canada’s pharmaceutical environment less attractive to drug companies.
access to new drugs
January 18, 2022
10:58AM
Drug developers are more likely to invest in research and development if prices for their medicines are high.
July 28, 2021
11:39AM
New drugs are approved later in Canada than in the United States and European Union.
June 3, 2021
9:29AM
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
May 13, 2021
1:00AM
October 29, 2020
12:02PM
Last year, British Columbia became the first province to introduce a mandatory biosimilar switching program for non-medical reasons.
June 5, 2020
10:27AM
New clinical trials registered with Health Canada fell by more than 52 per cent.
July 4, 2019
9:39AM
More regulation will likely lead to slower and more limited access to drugs.
March 18, 2019
3:03PM
Unfortunately, the federal government’s track record of creating reliable and accurate data systems is not good.
March 14, 2019
11:41AM
A national formulary—essentially a list of drugs—is unlikely to match the comprehensive lists covered by private insurance plans.